Fertmann Jan, Wolf Hilde, Kuchenhoff Helmut, Hofner Benjamin, Jauch Karl-Walter, Hartl Wolfgang H
Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich - Germany.
J Nephrol. 2008 Nov-Dec;21(6):909-18.
Acute mortality of unselected critically ill patients has improved during the last 15 years. Whether these benefits also affect long-term survival of critically ill surgical patients with severe acute renal failure is unclear, as are the prognostic factors relevant for survival time or mortality.
We performed a retrospective analysis of data collected prospectively from March 1993, through February 2005. Data from a cohort of 170 consecutive postoperative patients without preceding kidney diseases but requiring continuous renal replacement therapy (CRRT) during intensive care unit (ICU) stay were analyzed.
Six-month survival rate after ICU admission was 20.6%. In patients surviving more than 6 months, 5-year survival was 71.6%. After adjustment for relevant covariates, older age, disease severity at ICU admission, peritonitis and a large number of red cell units transfused during ICU stay were associated with worse 6-month prognosis. Duration of CRRT, and the origin and type of kidney failure were unimportant for prognosis, as was ICU admission date.
Six-month prognosis of critically ill surgical patients with severe acute renal failure is poor and mostly determined by the disease severity at ICU admission and by the frequency of surgical complications. Outcome had not improved over the study period, but after successful surgical and intensive care therapy, long-term survival appears to be reasonably good.
在过去15年中,未经挑选的危重症患者的急性死亡率有所改善。目前尚不清楚这些益处是否也会影响患有严重急性肾衰竭的危重症外科患者的长期生存率,以及与生存时间或死亡率相关的预后因素。
我们对1993年3月至2005年2月前瞻性收集的数据进行了回顾性分析。分析了一组170例连续术后患者的数据,这些患者既往无肾脏疾病,但在重症监护病房(ICU)住院期间需要持续肾脏替代治疗(CRRT)。
ICU入院后6个月生存率为20.6%。存活超过6个月的患者,5年生存率为71.6%。在对相关协变量进行调整后,年龄较大、ICU入院时疾病严重程度、腹膜炎以及ICU住院期间输注大量红细胞单位与6个月预后较差相关。CRRT持续时间、肾衰竭的起源和类型对预后并不重要,ICU入院日期也是如此。
患有严重急性肾衰竭的危重症外科患者的6个月预后较差,主要由ICU入院时的疾病严重程度和手术并发症的发生率决定。在研究期间,结果并未改善,但经过成功的手术和重症监护治疗后,长期生存率似乎相当不错。